PTC Therapeutics | PTCT - Ativos





Ativos Alterar Data
Acadia Pharmaceuticals USD 1.74B 137.67M 2026-06
Alnylam Pharmaceuticals USD 5.56B 429.22M 2026-06
Amgen USD 95.64B 3.14B 2026-06
BioCryst Pharmaceuticals USD 557.85M 92.8M 2026-06
Biogen USD 32.09B 2.6B 2026-06
BioMarin Pharmaceutical USD 11.72B 3.13B 2026-06
Cytokinetics USD 1.92B 651.07M 2026-06
Daiichi Sankyo JPY 4.11T 109.16B 2026-06
Enanta Pharmaceuticals USD 329.5M 48.77M 2025-12
Gilead Sciences USD 49.36B 6.92B 2026-06
Incyte USD 7.87B 533.53M 2026-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
Ironwood Pharmaceuticals USD 434.57M 37.66M 2026-03
Karyopharm Therapeutics USD 131.42M 23M 2026-03
Novartis USD 122.03B 3.5B 2026-06
Pfizer USD 201.13B 6.49B 2026-06
PTC Therapeutics USD 3.25B 381.37M 2026-06
Puma Biotechnology USD 202.86M 7.95M 2025-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.19B 9.58M 2026-06
TG Therapeutics USD 1.64B 110.79M 2026-06
Ultragenyx Pharmaceutical USD 1.26B 32M 2026-06
Vertex Pharmaceuticals USD 27.42B 938.9M 2026-06
Xencor USD 724.96M 11.89M 2026-06